Literature DB >> 17802898

Chronic infections and genetic factors in the development of ischemic stroke.

Zoltan Kis1, Katalin Sas, Zsofia Gyulai, Balint Treso, Fruzsina Petrovay, Beatrix Kapusinszky, Marta Csire, Valeria Endresz, Katalin Burian, Yvette Mandi, Laszlo Vecsei, Eva Gonczol.   

Abstract

The aim of this study was to examine whether chronic infections and genetic factors of the host play roles in the pathophysiology of acute noncardioembolic ischemic stroke. Blood samples from 59 subjects with ischemic stroke and 52 control patients were investigated by nested PCR for the presence of C. pneumoniae DNA, HCMV DNA and enterovirus RNA, by ELISA for the levels of antibodies to C. pneumoniae, HCMV, HSV, HHV-6, EBV and the inflammatory chemokine IL-8, and by PCR for promoter polymorphism of the IL-8 and CD14 host genes. Associations of stroke with the HCMV IgG and HSV-1 IgA antibody levels were observed. No association of stroke was detected with the presence of C. pneumoniae, HCMV or enterovirus nucleic acids in the peripheral blood, C. pneumoniae IgM, IgG and IgA, the HSV IgG, the EBV IgG, or HHV-6 IgG antibody levels, the pathogen burden, the IL-8 or CD14 promoter polymorphisms, or with the serum levels of IL-8 in the overall study population. These results are consistent with the hypothesis that certain pathogens are involved in the development of ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17802898

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  17 in total

1.  Viral and parasitic pathogen burden and the association with stroke in a population-based cohort.

Authors:  Brad D Pearce; Anna Bracher; Jeffrey L Jones; Deanna Kruszon-Moran
Journal:  Int J Stroke       Date:  2017-09-15       Impact factor: 5.266

Review 2.  Common infections and the risk of stroke.

Authors:  Armin J Grau; Christian Urbanek; Frederick Palm
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

3.  Infectious burden and risk of stroke: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Pankajavalli Ramakrishnan; Yeseon P Moon; Bernadette Boden-Albala; Khin M Liu; Steve L Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Arch Neurol       Date:  2009-11-09

4.  Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Moyses Szklo; Jingzhong Ding; Michael Y Tsai; Mary Cushman; Joseph F Polak; João Lima; R Graham Barr; A Richey Sharrett
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-10       Impact factor: 2.160

5.  CD14 C260T promoter polymorphism and the risk of cerebrovascular diseases: a meta-analysis.

Authors:  I Banerjee
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

Review 6.  Cerebral small vessel disease: genetic risk assessment for prevention and treatment.

Authors:  Ada Lam; M Anne Hamilton-Bruce; Jim Jannes; Simon A Koblar
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

7.  Infectious burden and carotid plaque thickness: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Jorge M Luna; Yeseon Park Moon; Bernadette Boden-Albala; Khin M Liu; Steven Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Stroke       Date:  2010-01-14       Impact factor: 7.914

8.  Role of TLR4 (C1196T) and CD14 (C-260T) Polymorphisms in Development of Ischemic Stroke, Its Subtypes and Hemorrhagic Stroke.

Authors:  Satrupa Das; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  J Mol Neurosci       Date:  2017-09-30       Impact factor: 3.444

9.  Antibody levels to persistent pathogens and incident stroke in Mexican Americans.

Authors:  Shawnita Sealy-Jefferson; Brenda W Gillespie; Allison E Aiello; Mary N Haan; Lewis B Morgenstern; Lynda D Lisabeth
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

10.  Intracranial Large Artery Stenosis and Past Infectious Exposures: Results From the NOMAS Cohort.

Authors:  Amol Mehta; Farid Khasiyev; Clinton B Wright; Tatjana Rundek; Ralph L Sacco; Mitchell S V Elkind; Jose Gutierrez
Journal:  Stroke       Date:  2022-02-02       Impact factor: 10.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.